Brazil Sets Sights On Biogen’s Spinraza For First Risk Sharing Deal
Executive Summary
As Brazil turns to risk sharing agreements to improve access to expensive treatments, the health ministry has its eye on Biogen’s rare disease treatment Spinraza (nusinersen).